I63
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Ischaemic stroke with hemiparesis less than nine moths ago Functional Ambulation Category (FAC) 2-5
Exclusion criteria
Exclusion criteria: Serious vascular diseases: Acute thrombosis, thrombophlebitis, PAD stage 3, lymphangitis, advanced arteriosclerosis (especially cerebral sclerosis) Serious metabolic and cardiac diseases (relative and absolute exclusion criteria): -Recurrent cardiovascular problems, decompensated heart failure NYHA IV, serious metabolic diseases Other diseases: Diseases of the skin, open wounds, skin infections, tumors, acute injuries to the musculoskeletal system, inflammatory muscle diseases, acute infections accompanied by fever, acute allergic diseases, serious orthopedic diseases of the spine (e.g. spinal canal stenosis) and/or large joints, severe or newly occurring pain (pain syndrome) Other exclusion or discontinuation criteria Significant cognitive impairment, language barriers, aphasia
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Functional ambulation category (FAC) for the assessment of walking ability The measurement instrument is an established assessment for evaluating the walking ability of rehabilitants after stroke (see Mehrholz et al., 2007; Park & An, 2016). 2. 10-metre walk test and Perry classification for the assessment of walking speed This method was developed in the study by Perry et al. (1995) and enables patients to be classified into different mobility categories. 3. Standardised 6-minute walk test to determine the walking distance The test allows a valid assessment of the patient's endurance and walking ability over a longer period of time (Dunn et al., 2015; Macchiavelli et al., 2021; Regan et al., 2020). | — |
Secondary
| Measure | Time frame |
|---|---|
| 4. Modified Ashworth scale for the assessment of spasticity This scale represents a standardised method for assessing muscle stiffness, which has been employed in a number of studies to evaluate spasticity (Ansari et al. (2022), Freire et al. (2023), Harb & Kishner (2023) and Meseguer-Henarejos et al. (2018)). 5. The de Morton Mobility Index (DEMMI) The index is employed for the assessment of mobility (Braun et al. (2018) and de Morton et al. (2008)). | — |
Countries
Germany
Contacts
Asklepios Weserberglandklinik